Contact this trialFirst, we need to learn more about you.
mTOR inhibitor
Everolimus for Acoustic Neuroma
Recruiting1 awardPhase 2
Los Angeles, California
This trial tests if RAD001 can shrink or slow the growth of tumors in NF2 patients and improve their hearing. RAD001 is a pill that blocks signals promoting tumor growth. It has shown effectiveness against various tumor types.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.